0000950170-24-073354.txt : 20240614 0000950170-24-073354.hdr.sgml : 20240614 20240614083010 ACCESSION NUMBER: 0000950170-24-073354 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240611 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGM Biosciences, Inc. CENTRAL INDEX KEY: 0001496323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770349194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39045 FILM NUMBER: 241043221 BUSINESS ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-965-7873 MAIL ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: Palingen, Inc. DATE OF NAME CHANGE: 20100712 8-K 1 igms-20240611.htm 8-K 8-K
false000149632300014963232024-06-112024-06-11

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 11, 2024

 

 

IGM Biosciences, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39045

77-0349194

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

325 E. Middlefield Road

 

Mountain View, California

 

94043

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (650) 965-7873

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

IGMS

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

See the information set forth below in Item 5.07 of this Current Report on Form 8-K, which is incorporated into this Item 5.02 by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 11, 2024, IGM Biosciences, Inc. (the “Company”) held its 2024 annual meeting of stockholders (the “Annual Meeting”). Of the 33,566,071 shares of common stock outstanding of April 15, 2024, the record date for the Annual Meeting, 30,182,714 shares of common stock were present in person (including virtually) or by proxy at the Annual Meeting, representing approximately 89.9% of the shares entitled to vote at the Annual Meeting and constituting a quorum for the transaction of business. The proposals voted upon at the meeting and the final voting results with respect to each proposal are as set forth below.

Proposal 1: Election of Directors

Each of the following nominees was elected to serve as a Class II director to serve until the Company’s 2027 annual meeting of stockholders or until his or her respective successor is duly elected and qualified.

 

 

 

 

 

 

 

 

 

 

 

 

 

Nominee

 

For

 

 

Withheld

 

 

Broker Non-Votes

 

M. Kathleen Behrens, Ph.D.

 

 

27,438,899

 

 

 

733,239

 

 

 

2,010,576

 

Elizabeth H.Z. Thompson, Ph.D.

 

 

28,077,410

 

 

 

94,728

 

 

 

2,010,576

 

Christina Teng Topsøe

 

 

27,546,088

 

 

 

626,050

 

 

 

2,010,576

 

Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm

The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024, was ratified.

 

 

 

 

 

 

 

 

 

 

 

 

 

For

 

 

Against

 

 

Abstain

 

 

Broker Non-Votes

 

30,136,577

 

 

 

42,532

 

 

 

3,605

 

 

N/A

Proposal 3: Approval of the Certificate of Amendment to the IGM Biosciences, Inc. Amended and Restated Certificate of Incorporation

The approval of a certificate of amendment to the Company's amended and restated certificate of incorporation, which limits the liability of certain officers as permitted by Delaware law (the "Certificate of Amendment"), was approved.

 

 

 

 

 

 

 

 

 

 

 

 

 

For

 

 

Against

 

 

Abstain

 

 

Broker Non-Votes

 

27,942,900

 

 

 

226,567

 

 

 

2,671

 

 

2,010,576

A description of the Certificate of Amendment is included in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 26, 2024, which description is incorporated herein by reference. Such description does not purport to be complete, and is qualified in its entirety by reference to the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 hereto and is incorporated herein by reference.

Proposal 4: Approval of Stock Option Exchange Program for Employees

The approval of a stock option exchange program for employees (excluding the Company's chief executive officer and non-employee directors), was approved.

 

 

 

 

 

 

 

 

 

 

 

 

 

For

 

 

Against

 

 

Abstain

 

 

Broker Non-Votes

 

27,297,288

 

 

 

869,661

 

 

 

5,189

 

 

2,010,576

A description of the stock option exchange program for employees is included in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 26, 2024, which description is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

3.1

Certificate of Amendment to the IGM Biosciences, Inc. Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on June 11, 2024

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

IGM BIOSCIENCES, INC.

 

 

 

 

Date:

June 14, 2024

By:

/s/ Misbah Tahir

 

 

 

Misbah Tahir
Chief Financial Officer

 

 EX-3.1 2 igms-ex3_1.htm EX-3.1 EX-3.1

Exhibit 3.1

CERTIFICATE OF AMENDMENT

TO THE

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

OF

IGM BIOSCIENCES, INC.

 

IGM Biosciences, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows:

1.
The name of the Corporation is IGM Biosciences, Inc. The Corporation was originally incorporated pursuant to the General Corporation Law of the State of Delaware (“DGCL”) on August 25, 1993 under the name Palingen, Inc. The name of the Corporation was changed on October 13, 2010 to IGM Biosciences, Inc.
2.
This Certificate of Amendment to the Amended and Restated Certificate of Incorporation of IGM Biosciences, Inc. was duly adopted in accordance with Section 242 of the DGCL by the Board of Directors and the stockholders of the Corporation.
3.
Section 1, Article IX of the Corporation’s Amended and Restated Certificate of Incorporation is hereby amended and restated in its entirety to read as follows:

“Section 1. To the fullest extent permitted by the DGCL as the same exists or as may hereafter be amended from time to time, a director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer. If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors or officers, then the liability of a director or officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.”

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by a duly authorized officer of the Corporation, on June 11, 2024.

By: /s/ Fred Schwarzer_____________________

Name: Fred Schwarzer

Title: Chief Executive Officer and President

 

 

 EX-101.SCH 3 igms-20240611.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document And Entity Information
Jun. 11, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 11, 2024
Entity Registrant Name IGM Biosciences, Inc.
Entity Central Index Key 0001496323
Entity Emerging Growth Company true
Entity File Number 001-39045
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 77-0349194
Entity Address, Address Line One 325 E. Middlefield Road
Entity Address, City or Town Mountain View
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94043
City Area Code (650)
Local Phone Number 965-7873
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol IGMS
Security Exchange Name NASDAQ
EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports igms-20240611.htm igms-20240611.xsd http://xbrl.sec.gov/dei/2024 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "igms-20240611.htm": { "nsprefix": "igms", "nsuri": "http://igmbio.com/20240611", "dts": { "inline": { "local": [ "igms-20240611.htm" ] }, "schema": { "local": [ "igms-20240611.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_8601060e-7770-4ff5-916d-112e61bf095b", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "igms-20240611.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_8601060e-7770-4ff5-916d-112e61bf095b", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "igms-20240611.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://igmbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0000950170-24-073354-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-073354-xbrl.zip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end XML 15 igms-20240611_htm.xml IDEA: XBRL DOCUMENT 0001496323 2024-06-11 2024-06-11 false 0001496323 8-K 2024-06-11 IGM Biosciences, Inc. DE 001-39045 77-0349194 325 E. Middlefield Road Mountain View CA 94043 (650) 965-7873 false false false false Common Stock, par value $0.01 per share IGMS NASDAQ true false